Vitiligo Treatment Market

Global Vitiligo Treatment Market Size, Share & Trends Analysis Report By Type (Non-Segmental Vitiligo, and Segmental Vitiligo), By Treatment (Therapy, Surgery, and Medication), and By End-User (Hospitals, and Aesthetic Clinics) Forecast, 2022-2028

Published: Mar 2022 | Report Code: OMR2026304 | Category : Pharmaceuticals | Delivery Format: /

The global vitiligo treatment market is growing at a CAGR of 5.5% during the forecast period. One of the major factors that are augmenting the growth of the vitiligo treatment market is the increasing number of clinical trials, growing awareness among populations. Moreover, the growing accessibility for appropriate treatment along with the increasing development of a potential drug and evolvement of a new novel therapy is also estimated to be the other important factor that is contributing significantly towards the growth of the global vitiligo treatment market. 

However, the high cost of treatment and stringent regulation for drug development is some factor constraints that are hindering the growth of the global vitiligo treatment market across the globe. Moreover, undergoing clinical trials by various manufacturers in emerging regions are some of the key factors that are creating opportunities for the market. A new offering in the market is likely to drive the growth of the global vitiligo treatment market. For instance, in May 2020, TWi Biotechnology had announced that the company had received Clinical Trial Application (CTA) approval from Health Canada in order to perform a Phase 1 clinical trial with AC-1101 gel. The AC-1101 is considered a topical JAK inhibitor for the purpose of providing effective treatment to patients suffering from vitiligo. 

Impact of COVID-19 Pandemic on Global Vitiligo Treatment Market  

The COVID-19 pandemic had impacted various industries in an adverse manner. Additionally, the global vitiligo treatment market is hardly hit by the COVID-19 pandemic since December 2019. The outbreak of COVID-19 in these major economies has disrupted the manufacturing and transportation sector across the globe. This COVID-19 pandemic had also led to disturbance in health clinics, especially in the US. 

Segmental Outlook 

The market is segmented based on type, treatment, and end-user. By type, the market is segmented into non-segmental vitiligo and segmental vitiligo. Further, based on the treatment segment, the market is segmented into therapy, surgery, and medication. Based on the end-user segment, the market is divided into hospitals and aesthetic clinics.

Global Vitiligo Treatment Market Share Type, 2021 (%) 

Global Vitiligo Treatment Market Share Type

Non-Segmental Vitiligo Expected to Hold Prominent Market Share in the Global Vitiligo Treatment Market  

Based on the type, the non-segmental vitiligo segment holds a significant share in the vitiligo treatment market. Non-Segmental Vitiligo is considered as a condition in which pigment on an individual's skin starts to lose its color creating. The patches on the body appear to be equal on both sides where it is present. Generally, it is observed that non-segmental vitiligo commences near the hands, around the eyes or mouth, on the feet, or in an area of the body where the skin rubs together frequently. Additionally, the color loss comes in over the course of one’s life, spreading and becoming more observable as time pass on.

Regional Outlooks

The global vitiligo treatment market is analyzed based on the geographical regions that are contributing significantly towards the growth of the market. Based on the geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America held a considerable share in the global vitiligo treatment market. Some factors that are boosting the market growth in North America are growing technological advancement in treatment methods and the present increasing cases related prevalence of vitiligo. 

Global Vitiligo Treatment Market Growth, by Region 2022-2028 

Global Vitiligo Treatment Market Growth, by Region

Asia-Pacific will have considerable growth in the Global Vitiligo Treatment Market   

The Asia-Pacific region is expected to witness significant growth opportunities for the market. Growing per capita healthcare expenditure along with increasing health awareness and disease awareness, among people, is acting as the prime factor impacting the market in the region. Additionally, increasing adoption of new technology and drug and industry players are having large scope in this region especially in South Korea, China, and India for increasing their activity in the market.

Market Players Outlook

The prominent players functioning in the global vitiligo treatment market include AVITA Medical, Incyte Corp., TWi Biotechnology, Dermavant Sciences, Inc., and Clinuvel Pharmaceuticals Ltd. among others. These key manufacturers are adopting various strategies such as new product launches and approvals, mergers and acquisitions, partnerships, and collaborations, and many others to thrive in a competitive environment. For instance, in December 2021, FDA had agreed to Phase II study CUV104 that would be evaluating CLINUVEL’s drug SCENESSE which is considered as a monotherapy in patients with the depigmentation disorder vitiligo. Additionally, Clinuvel Pharmaceuticals Ltd. had reached an agreement on the clinical protocol and will commence the CUV104 study at a specialist hospital department in the US.

In October 2020, Avita Medical which is considered as one of the regenerative medicine companies, which had launched a clinical study in order to evaluate for the purpose of analyzing the safety and effectiveness of its RECELL System in the effective treatment of vitiligo. The RECELL System is considered as a system utilizing a small amount of a patient’s healthy skin to prepare a suspension of Spray-On Skin Cells, which is then applied to the vitiligo.

In December 2019, Dermavant Sciences Inc. had set forth the information for its dose of Phase 2a vitiligo clinical trial for topical cerdulatinib. The Cerdulatinib is considered as a dual inhibitor of the Janus kinase (JAK) and spleen tyrosine kinase (Syk) pathways, which the company is evaluating as a differentiated topical treatment option for vitiligo.

The Report Covers

  • Market value data analysis of 2021 and forecast to 2028.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global vitiligo treatment market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market entry and market expansion strategies.
  • Competitive strategies by identifying ‘who-stands-where’ in the market.

1. Report Summary

1.1. Research Methods and Tools

1.2. Market Breakdown

1.2.1. By Segments

1.2.2. By Geography

2. Market Overview and Insights

2.1. Scope of the Report

2.2. Analyst Insight & Current Market Trends

2.2.1. Key Findings

2.2.2. Recommendations

2.2.3. Conclusion

3. Competitive Landscape

3.1. Key Company Analysis

3.1.1. Overview  

3.1.2. Financial Analysis 

3.1.3. SWOT Analysis

3.1.4. Recent Developments

3.2. Key Strategy Analysis

3.3. Impact of Covid-19 on Key Players       

4. Market Segmentation

4.1. Global Vitiligo Treatment Market by Type

4.1.1. Non-Segmental Vitiligo 

4.1.2. Segmental Vitiligo

4.2. Global Vitiligo Treatment Market by Treatment

4.2.1. Therapy

4.2.2. Surgery

4.2.3. Medication

4.3. Global Vitiligo Treatment Market by End-User

4.3.1. Hospitals

4.3.2. Aesthetic Clinics

5. Regional Analysis

5.1. North America

5.1.1. United States

5.1.2. Canada

5.2. Europe

5.2.1. UK

5.2.2. Germany

5.2.3. Italy

5.2.4. Spain

5.2.5. France

5.2.6. Rest of Europe 

5.3. Asia-Pacific

5.3.1. China

5.3.2. India

5.3.3. Japan

5.3.4. South Korea

5.3.5. Rest of Asia-Pacific 

5.4. Rest of the World

6. Company Profiles 

6.1. Arcutis Biotherapeutics

6.2. AVITA Medical

6.3. CLINUVEL PHARMACEUTICALS LTD.

6.4. Bioniz Therapeutics

6.5. Dr. Reddy’s Laboratories Ltd. 

6.6. Dermavant Sciences, Inc.

6.7. Edesa Biotech, Inc.

6.8. Eli Lilly and Co.

6.9. Incyte Corp.

6.10. TWi Biotechnology

6.11. Temprian Therapeutics Inc.

6.12. STRATA Skin Sciences

6.13. Pfizer Inc.

1. GLOBAL VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)

2. GLOBAL NON-SEGMENTAL VITILIGO MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)

3. GLOBAL SEGMENTAL VITILIGO MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)

4. GLOBAL VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)

5. GLOBAL THERAPY FOR VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)

6. GLOBAL SURGERY FOR VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)

7. GLOBAL MEDICATION FOR VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)

8. GLOBAL VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

9. GLOBAL HOSPITALS FOR VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)

10. GLOBAL AESTHETIC CLINICS FOR VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)

11. GLOBAL VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)

12. NORTH AMERICAN VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)

13. NORTH AMERICAN VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)

14. NORTH AMERICAN VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)

15. NORTH AMERICAN VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

16. EUROPEAN VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)

17. EUROPEAN VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)

18. EUROPEAN VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)

19. EUROPEAN VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

20. ASIA-PACIFIC VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)

21. ASIA-PACIFIC VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)

22. ASIA-PACIFIC VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)

23. ASIA-PACIFIC VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

24. REST OF WORLD VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)

25. REST OF WORLD VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2020-2027 ($ MILLION)

26. REST OF WORLD VITILIGO TREATMENT MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)

1. IMPACT OF COVID-19 ON GLOBAL VITILIGO TREATMENT MARKET, 2020-2027 ($ MILLION)

2. IMPACT OF COVID-19 ON GLOBAL VITILIGO TREATMENT MARKET BY SEGMENT, 2020-2027 ($ MILLION)

3. RECOVERY OF GLOBAL VITILIGO TREATMENT MARKET, 2021-2027 (%)

4. GLOBAL VITILIGO TREATMENT MARKET SHARE BY TYPE, 2020 VS 2027 (%)

5. GLOBAL NON-SEGMENTAL VITILIGO MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)

6. GLOBAL SEGMENTAL VITILIGO MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)

7. GLOBAL VITILIGO TREATMENT MARKET SHARE BY TREATMENT, 2020 VS 2027 (%)

8. GLOBAL THERAPY FOR VITILIGO TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)

9. GLOBAL SURGERY FOR VITILIGO TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)

10. GLOBAL MEDICATION FOR VITILIGO TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)

11. GLOBAL VITILIGO TREATMENT MARKET SHARE BY END-USER, 2020 VS 2027 (%)

12. GLOBAL HOSPITALS FOR VITILIGO TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)

13. GLOBAL AESTHETIC CLINICS FOR VITILIGO TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)

14. GLOBAL VITILIGO TREATMENT MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)

15. US VITILIGO TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)

16. CANADA VITILIGO TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)

17. UK VITILIGO TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)

18. FRANCE VITILIGO TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)

19. GERMANY VITILIGO TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)

20. ITALY VITILIGO TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)

21. SPAIN VITILIGO TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)

22. REST OF EUROPE VITILIGO TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)

23. INDIA VITILIGO TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)

24. CHINA VITILIGO TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)

25. JAPAN VITILIGO TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)

26. SOUTH KOREA VITILIGO TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)

27. REST OF ASIA-PACIFIC VITILIGO TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)

28. REST OF THE WORLD VITILIGO TREATMENT MARKET SIZE, 2020-2027 ($ MILLION)